Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

462
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
462
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

307
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
307
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

386
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
386
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

638
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
638
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.2K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.2K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

688
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
688

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hnrnpa1 is essential for early zebrafish development and lipid metabolism: insights from a novel zebrafish knockout model.

Frontiers in cell and developmental biology·2026
Same author

Polypharmacy Among 200 000 Subjects of the Population-Based German National Cohort Study (NAKO), Aged 19-74: A Baseline Analysis.

Deutsches Arzteblatt international·2026
Same author

Acylcarnitines and prediction of renal function decline in type 2 diabetes.

BMJ open diabetes research & care·2026
Same author

Optimization of a targeted metabolomics kit for dried blood spots analysis and longitudinal comparison with serum.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

Txnrd2 loss in skeletal muscle causes muscle atrophy and drives leanness and obesity resistance.

Redox biology·2026
Same author

Care delay during the COVID-19 pandemic in Germany - a cross-sectional online survey in the NAKO study.

BMC public health·2026

Related Experiment Video

Updated: Mar 15, 2026

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

4.3K

Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.

Stefan Dietrich1, Anna Floegel2, Martina Troll3,4

  • 1Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany stefan.dietrich@dife.de.

International Journal of Epidemiology
|September 4, 2016
PubMed
Summary

A new Random Survival Forest (RSF) method effectively identifies type 2 diabetes (T2D)-associated metabolites in complex cohort data. This approach improves T2D prediction and handles correlated variables better than traditional methods.

Keywords:
Cox proportional hazards regressionexploratory survival analysismetabolomicsmulticollinearityrandom survival forestright-censored datatype 2 diabetes mellitusvariable selection

More Related Videos

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.2K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.9K

Related Experiment Videos

Last Updated: Mar 15, 2026

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

4.3K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.2K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.9K

Area of Science:

  • Metabolomics
  • Epidemiology
  • Biostatistics

Background:

  • Metabolomics in prospective cohort studies presents statistical challenges.
  • Selecting disease-associated metabolites from highly correlated, complex data requires robust statistical methods.

Purpose of the Study:

  • To develop and validate a statistical approach for identifying disease-associated metabolites in prospective cohort studies.
  • To compare the performance of Random Survival Forest (RSF) with traditional Cox regression for metabolite selection.

Main Methods:

  • Combined Random Survival Forest (RSF) with automated backward elimination for metabolite selection.
  • Applied the RSF approach to serum metabolite data from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study.
  • Validated the method by comparing RSF and Cox regression in two independent cohorts.

Main Results:

  • Identified 16 incident type 2 diabetes mellitus (T2D)-associated metabolites using the RSF approach in the EPIC-Potsdam cohort.
  • The identified metabolites slightly improved T2D prediction when added to traditional risk factors or classical biomarkers.
  • RSF selected a higher number of correlated metabolites compared to Cox regression, indicating its ability to handle multicollinearity.

Conclusions:

  • The RSF method is a promising approach for identifying disease-associated variables in high-dimensional, time-to-event data.
  • RSF offers comparable findings to Cox regression while effectively addressing multicollinearity.
  • The study provides R-code for implementing the RSF-based metabolite selection procedure.